This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1k2b

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1k2b.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1k2b.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1k2b| PDB=1k2b | SCENE= }}
{{STRUCTURE_1k2b| PDB=1k2b | SCENE= }}
-
'''Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance'''
+
===Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance===
-
==Overview==
+
<!--
-
HIV-1 develops resistance to protease inhibitors predominantly by selecting mutations in the protease gene. Studies of resistant mutants of HIV-1 protease with single amino acid substitutions have shown a range of independent effects on specificity, inhibition, and stability. Four double mutants, K45I/L90M, K45I/V82S, D30N/V82S, and N88D/L90M were selected for analysis on the basis of observations of increased or decreased stability or enzymatic activity for the respective single mutants. The double mutants were assayed for catalysis, inhibition, and stability. Crystal structures were analyzed for the double mutants at resolutions of 2.2-1.2 A to determine the associated molecular changes. Sequence-dependent changes in protease-inhibitor interactions were observed in the crystal structures. Mutations D30N, K45I, and V82S showed altered interactions with inhibitor residues at P2/P2', P3/P3'/P4/P4', and P1/P1', respectively. One of the conformations of Met90 in K45I/L90M has an unfavorably close contact with the carbonyl oxygen of Asp25, as observed previously in the L90M single mutant. The observed catalytic efficiency and inhibition for the double mutants depended on the specific substrate or inhibitor. In particular, large variation in cleavage of p6(pol)-PR substrate was observed, which is likely to result in defects in the maturation of the protease from the Gag-Pol precursor and hence viral replication. Three of the double mutants showed values for stability that were intermediate between the values observed for the respective single mutants. D30N/V82S mutant showed lower stability than either of the two individual mutations, which is possibly due to concerted changes in the central P2-P2' and S2-S2' sites. The complex effects of combining mutations are discussed.
+
The line below this paragraph, {{ABSTRACT_PUBMED_12012342}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 12012342 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_12012342}}
==About this Structure==
==About this Structure==
Line 36: Line 40:
[[Category: Inhibitor]]
[[Category: Inhibitor]]
[[Category: X-ray diffraction]]
[[Category: X-ray diffraction]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 22:12:49 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 21:26:17 2008''

Revision as of 18:26, 1 July 2008

Image:1k2b.png

Template:STRUCTURE 1k2b

Combining Mutations in HIV-1 Protease to Understand Mechanisms of Resistance

Template:ABSTRACT PUBMED 12012342

About this Structure

1K2B is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

Reference

Combining mutations in HIV-1 protease to understand mechanisms of resistance., Mahalingam B, Boross P, Wang YF, Louis JM, Fischer CC, Tozser J, Harrison RW, Weber IT, Proteins. 2002 Jul 1;48(1):107-16. PMID:12012342

Page seeded by OCA on Tue Jul 1 21:26:17 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1k2b"
Personal tools